Orion Portfolio Solutions, LLC Neurocrine Biosciences Inc Transaction History

Orion Portfolio Solutions, LLC

$9.43 Billion
Q3 2024

A detailed history of Orion Portfolio Solutions, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 26,934 shares of NBIX stock, worth $3.68 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

26,934

Previous 27,155 0.81%

Holding current value

$3.68 Million

Previous $3.74 Million 17.07%

% of portfolio

0.03%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$114.58 - $153.15 $25,322 - $33,846	-221 Reduced 0.81%	26,934 $3.1 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $236,856 - $259,173	-1,810 Reduced 6.25%	27,155 $3.74 Million
Q1 2024 May 09, 2024	SELL	$130.4 - $143.74 $63,896 - $70,432	-490 Reduced 1.66%	28,965 $3.99 Million
Q4 2023 Feb 09, 2024	SELL	$106.07 - $132.76 $291,586 - $364,957	-2,749 Reduced 8.54%	29,455 $3.88 Million
Q3 2023 Nov 01, 2023	BUY	$94.02 - $117.1 $375,421 - $467,580	3,993 Added 14.15%	32,204 $3.62 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $318,637 - $373,232	-3,559 Reduced 11.2%	28,211 $2.66 Million
Q1 2023 Aug 30, 2023	BUY	$94.11 - $123.02 $334,937 - $437,828	3,559 Added 12.62%	31,770 $3.22 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $2.99 Million - $3.91 Million	31,770 New	31,770 $3.22 Million
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $3,269 - $4,595	-34 Closed	0 $0
Q2 2020 Aug 19, 2020	BUY	$85.09 - $130.36 $255 - $391	3 Added 9.68%	34 $4,000
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $450 - $682	6 Added 24.0%	31 $3,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $2,170 - $2,964	25 New	25 $3,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.

Account

Orion Portfolio Solutions, LLC Neurocrine Biosciences Inc Transaction History